Laurion Capital Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-854
| Closed | -$272K | – | 467 |
|
2024
Q2 | $272K | Buy |
+854
| New | +$272K | ﹤0.01% | 329 |
|
2020
Q3 | – | Sell |
-2,142
| Closed | -$259K | – | 900 |
|
2020
Q2 | $259K | Buy |
+2,142
| New | +$259K | ﹤0.01% | 527 |
|
2020
Q1 | – | Sell |
-20,100
| Closed | -$1.77M | – | 736 |
|
2019
Q4 | $1.77M | Buy |
+20,100
| New | +$1.77M | 0.01% | 160 |
|
2018
Q3 | – | Sell |
-3,332
| Closed | -$377K | – | 1132 |
|
2018
Q2 | $377K | Buy |
3,332
+1,540
| +86% | +$174K | ﹤0.01% | 774 |
|
2018
Q1 | $201K | Sell |
1,792
-11,200
| -86% | -$1.26M | ﹤0.01% | 947 |
|
2017
Q4 | $1.92M | Buy |
12,992
+1,400
| +12% | +$207K | 0.01% | 424 |
|
2017
Q3 | $1.36M | Sell |
11,592
-145,151
| -93% | -$17M | 0.01% | 460 |
|
2017
Q2 | $20.3M | Buy |
156,743
+23,700
| +18% | +$3.07M | 0.11% | 36 |
|
2017
Q1 | $18M | Buy |
+133,043
| New | +$18M | 0.14% | 49 |
|
2016
Q4 | – | Sell |
-6,900
| Closed | -$815K | – | 869 |
|
2016
Q3 | $815K | Buy |
+6,900
| New | +$815K | 0.01% | 247 |
|